...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >The Combination of Aricept with a Traditional Chinese Medicine Formula, Smart Soup, May Be a Novel Way to Treat Alzheimer's Disease
【24h】

The Combination of Aricept with a Traditional Chinese Medicine Formula, Smart Soup, May Be a Novel Way to Treat Alzheimer's Disease

机译:Aricept与传统中药配方Smart Soup的结合可能是治疗阿尔茨海默氏病的新方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Alzheimer's disease (AD) is a common neurodegenerative disease affecting cognitive function in the elderly, which is characterized by the presence of extracellular deposits of insoluble amyloid-beta plaques and neuronal loss. Modern pharmacology and drug development usually follow a single-target principle, which might contribute to the failure of most compounds in clinical trials against AD. Considering AD is a multifactorial disease, a combination therapeutic strategy that applies drugs with different mechanisms would be an alternative way. Smart Soup (SS), a Traditional Chinese Medicine formula, is composed of three herbaceous plants and has been applied in the treatment of amnesia in China for hundreds of years. In this work, we studied the clinical potency of the combination of SS and Aricept in AD therapy. In the in vivo model, both longevity and locomotive activity of AD transgenic Drosophila were improved remarkably in the combined medicine treated group. We also observed less amyloid-beta deposition and retarded neuronal loss following the combined drug treatment. In the retrospective cohort study, we found the combination therapy exerted better therapeutic effect on AD patients. Our study revealed that combination therapy with multiple drug targets did have a better therapeutic outcome. It provides a new strategy to develop an optimum pharmaceutical approach against AD.
机译:阿尔茨海默氏病(AD)是一种影响老年人认知功能的常见神经退行性疾病,其特征是存在不溶性淀粉样β斑块的细胞外沉积和神经元丢失。现代药理学和药物开发通常遵循单一目标原则,这可能导致大多数化合物在针对AD的临床试验中失败。考虑到AD是一种多因素疾病,采用具有不同机制的药物的联合治疗策略将是另一种选择。智能汤(SS)是一种传统的中药配方,由三种草本植物组成,已经在中国治疗失忆症已有数百年历史。在这项工作中,我们研究了SS和Aricept组合在AD治疗中的临床效力。在体内模型中,联合药物治疗组的AD转基因果蝇的寿命和机车活性均得到显着改善。我们还观察到联合药物治疗后淀粉样β沉积减少,神经元丢失受到延迟。在回顾性队列研究中,我们发现联合疗法对AD患者具有更好的治疗效果。我们的研究表明,具有多种药物靶标的联合治疗确实具有更好的治疗效果。它为开发针对AD的最佳药物治疗方法提供了新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号